Regalden 400mg 15 Caps, Gabapentin
Epilepsy: Gabapentin is indicated as monotherapy for partial seizures, with or without secondary generalization in adults and children over 12 years.
Gabapentin is indicated as adjunctive therapy in the treatment of partial seizures with or without secondary generalization in adults and children over 3 years.
Neuropathic Pain: Gabapentin is indicated for the treatment of neuropathic pain in patients 18 years of age and older.
Contraindications Gabapentin is contraindicated in patients who have shown hypersensitivity to gabapentin or ingredients.
General: Although there is no evidence of rebound seizures with gabapentin, the sudden interruption in the administration of anticonvulsant drugs in epileptic patients may cause status epilepticus (see
DOSAGE AND ADMINISTRATION.)
In general, gabapentin is not considered to be useful for the treatment of absence seizures.
Patients who received concomitant treatment with morphine may experience increases in the concentration of gabapentin. Patients should be watched carefully because of signs of central nervous system depression, drowsiness, and the dose of gabapentin or morphine should be reduced appropriately.
Effects on ability to drive motor vehicles or use machines Patients should be advised not to drive or use potentially dangerous machinery until you know if this medication does not affect your ability to perform these activities.
Drug Name: REGALDEN
Comparable patent medicine: Neurontin
Active ingredient: Gabapentin
Concentration: 400 mg
Extended-release tablets: No
Laboratory MAVI S. A. DE CV
BOX 15 capsules
Made in: Mexico